DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Follath F. et al.
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
Lancet 2002;
360: 196-202
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.